Assessment of the Taste Properties of Atazanavir and Cobicistat and Pediatric Oral Test Formulations Containing Both Atazanavir and Cobicistat in Healthy Adults

Trial Profile

Assessment of the Taste Properties of Atazanavir and Cobicistat and Pediatric Oral Test Formulations Containing Both Atazanavir and Cobicistat in Healthy Adults

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 22 May 2017

At a glance

  • Drugs Atazanavir/cobicistat (Primary) ; Atazanavir; Cobicistat
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 23 Jan 2017 Planned End Date changed from 1 Jul 2016 to 1 Jul 2018.
    • 23 Jan 2017 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2018.
    • 08 Aug 2016 Planned End Date changed from 1 Oct 2016 to 1 Jul 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top